New York University Cancer Center
New York, New York 10016
We've found
1 trials
at this facility
Mesothelioma Clinical Trial
Updated: 5/22/2008
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
Status: Enrolling,
Phase
II
Updated: 5/22/2008
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)